"With our market-leading innovations and our investments in research and healthcare IT solutions, we have the ability to support the fight against cancer together with MolecularHealth," said Jim Hagemann Snabe, co-CEO, SAP AG. "We partner and drive co-innovation with companies that are dedicated to making a difference. Our investment in technologies and platforms such as SAP HANA, cloud and enterprise mobility enables us and our partners to deliver on our vision and commitment to make the world run better and to improve people's lives."For more information, visit the SAP Newsroom. Next Major Event: SAPPHIRE® NOW + SAP® TechEd Madrid In 2012, SAP again brings together its largest ecosystem education event series with its premier customer conference for a co-located event to be held in Madrid, Spain, from November 13-16. With SAPPHIRE® NOW, SAP offers its customers, partners, and prospects even more opportunities to engage in dialogue with peers, participants and thought leaders around the globe, and can gain insight as to how SAP is delivering on its product strategy and helping organizations around the world to run better. SAP® TechEd brings IT managers, software developers, administrators, and business process experts together to learn in an interactive environment directly from the experts responsible for cutting-edge SAP technology. The co-located event provides access to the entire SAP ecosystem and enables attendees to learn how SAP can help their organizations run like never before. Follow on Twitter at @SAPPHIRENOW and @SAPTechEd, and join the conversation at #SAPPHIRENOW and #SAPTechEd. About MolecularHealth MolecularHealth, a clinico-molecular informatics company, is advancing precision medicine by translating patient-specific molecular and genomic data, clinical history and published scientific and medical evidence into safer, more effective drug choices for patients. The company's solutions range from a next generation drug safety assessment and prediction tool that analyzes the molecular basis of adverse events to a treatment decision support system that transforms genome sequences into evidence-based treatment strategies for cancer patients. MolecularHealth's collaborators include the University of Texas MD Anderson Cancer Center and the U.S. Food and Drug Administration (FDA). For more information visit www.molecularhealth.com. About SAP As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 197,000 customers to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com. Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.